子類別 報告 [0/1] 專利 [0/11] 期刊論文 [193/194] 會議論文/會議摘要 [41/48] 鄰近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群統計 近3年內發表的文件:0(0.00%) 含全文筆數:234(92.13%) 文件下載次數統計 下載大於0次:234(100.00%) 下載大於100次:234(100.00%) 檔案下載總次數:146965(2.74%) 最後更新時間: 2024-12-01 08:22 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-10 / 254. (共26頁) 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-16	Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues	Frontiers in Oncology. 2021 Nov 16;11:Article number 769665.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04	Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy	Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-01-12	Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells	Scientific Reports. 2021 Jan 12;11:Article number 644.
2020-08	The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells	Toxicology and Applied Pharmacology. 2020 Aug;401:Article number 115080.
2020-07-17	Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer[Erratum:Scientific Reports. 2019 Mar;9:Article number 3931.]	Scientific Reports. 2020 Jul 17;10:Article number 12216.
2020-06-28	Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction	Cancers. 2020 Jun 28;12(7):Article number 1718.
2020-06	Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice	European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.

顯示項目1-10 / 254. (共26頁) 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目